参考文献/References:
［1］Bouet P E, Godbout A, Elhachem H, et al.Fertility and pregnancy in turner syndrome ［J］.Journal of Obstetrics and Gynaecology Canada: JOGC, 2016, 38（8）: 712718.
［2］Gravholt C H, Andersen N H, Conway G S, et al.Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting ［J］.European Journal of Endocrinology, 2017, 177（3）: G1G70.
［3］Davenport M L.Approach to the patient with Turner syndrome ［J］.The Journal of Clinical Endocrinology and Metabolism, 2010, 95（4）: 14871495.
［4］Folsom L J, Fuqua J S.Reproductive issues in women with Turner syndrome ［J］.Endocrinology and Metabolism Clinics of North America, 2015, 44（4）: 723737.
［5］Oktay K, Bedoschi G.Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects ［J］.Fertility and Sterility, 2019, 111（6）: 11241126.
［6］Reindollar R H.Turner syndrome: contemporary thoughts and reproductive issues ［J］.Seminars in Reproductive Medicine, 2011, 29（4）: 342352.
［7］Hook E B, Warburton D.Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss ［J］.Human Genetics, 2014, 133（4）: 417424.
［8］Modi D N, Sane S, Bhartiya D.Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads ［J］.Molecular Human Reproduction, 2003, 9（4）: 219225.
［9］Alves M, Bastos M, Almeida S T, et al.Gonadal function in Turner syndrome ［J］.Acta Medica Portuguesa, 2013, 26（6）: 655663.
［10］ Mamsen L S, Charkiewicz K, Anderson R A, et al.Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation ［J］.Fertility and Sterility, 2019, 111（6）: 12171225.e3.
［11］ Mortensen K H, Rohde M D, Uldbjerg N, et al.Repeated spontaneous pregnancies in 45,X Turner syndrome ［J］.Obstetrics and Gynecology, 2010, 115（2 Pt 2）: 446449.
［12］ Quilter C R, Karcanias A C, Bagga M R, et al.Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure （POF） ［J］.Human Reproduction （Oxford, England）, 2010, 25（8）: 21392150.
［13］Mercer C L, Lachlan K, Karcanias A, et al.Detailed clinical and molecular study of 20 females with Xq deletions with special reference to menstruation and fertility ［J］.European Journal of Medical Genetics, 2013, 56（1）: 16.
［14］ Hagen C P, Aksglaede L, Srensen K, et al.Serum levels of antiMüllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients ［J］.The Journal of Clinical Endocrinology and Metabolism, 2010, 95（11）: 50035010.
［15］Lau N M, Huang J Y, Macdonald S, et al.Feasibility of fertility preservation in young females with Turner syndrome ［J］.Reproductive BioMedicine Online, 2009, 18（2）: 290295.
［16］Borgstr m B, Birgit B, Hreinsson J, et al.Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles ［J］.The Journal of Clinical Endocrinology and Metabolism, 2009, 94（1）: 7480.
［17］Chen C.Pregnancy after human oocyte cryopreservation ［J］.Lancet, 1986,1（8486）: 884886.
［18］Sole M, Santalo J, Boada M, et al.How does vitrification affect oocyte viability in oocyte donation cycles A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes ［J］.Human Reproduction, 2013, 28（8）: 20872092.
［19］Talaulikar V S, Conway G S, Pimblett A, et al.Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome ［J］.Fertility and Sterility, 2019, 111（3）: 505509.
［20］Balen A H, Harris S E, Chambers E L, et al.Conservation of fertility and oocyte genetics in a young Woman with Mosaic Turner syndrome ［J］.BJOG: an International Journal of Obstetrics and Gynaecology, 2010, 117（2）: 238242.
［21］Oktay K，RodriguezWallberg K A,sahin G.Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14yearold adolescent with turner syndrome mosaicism and impending premature ovarian failure ［J］.Fertility and Sterility, 2010, 94（2）: 715753.
［22］Hatirnaz , Ata B, Hatirnaz E S, et al.Oocyte in vitro maturation: A sytematic review ［J］.Turkish Journal of Obstetrics and Gynecology, 2018, 15（2）: 112125.
［23］Walls M L, Hart R J.In vitro maturation ［J］.Best practice & researchClinical obstetrics & gynaecology,2018,S1521693418301196.
［24］Huang J Y, Tulandi T, Holzer H, et al.Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome:Case report ［J］.Human Reproduction, 2008, 23（2）: 336339.
［25］Donnez J, Dolmans M M, Demylle D, et al.Livebirth after orthotopic transplantation of cryopreserved ovarian tissue ［J］.Lancet, 2004, 364（9443）: 14051410.
［26］Donnez J, Dolmans M M.Fertility preservation in women ［J］.The New England Journal of Medicine, 2017, 377（17）: 16571665.
［27］Donnez J, Dolmans M M, Diaz C, et al.Ovarian cortex transplantation: time to move on from experimental studies to open clinical application ［J］.Fertility and Sterility, 2015, 104（5）: 10971098.
［28］Vanderven H, Liebenthron J, Beckmann M, et al.Ninetyfive orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates ［J］.Human Reproduction （Oxford, England）, 2016, 31（9）: 20312041.
［29］Demeestere I, Simon P, Dedeken L, et al.Live birth after autograft of ovarian tissue cryopreserved during childhood ［J］.Human Reproduction, 2015, 30（9）: 21072109.
［30］Dolmans M M.Recent advances in fertility preservation and counseling for female cancer patients ［J］.Expert Review of Anticancer Therapy, 2018, 18（2）: 115120.
［31］Algarroba G N, Sanfilippo J S, Vallipulaski H.Female fertility preservation in the pediatric and adolescent cancer patient population ［J］.Best Practice & Research Clinical Obstetrics & Gynaecology, 2018, 48: 147157.
［32］Bjelland E K, Wilkosz P, Tanbo T G, et al.Is unilateral oophorectomy associated with age at menopause A population study （the HUNT2 Survey） ［J］.Human Reproduction （Oxford, England）, 2014, 29（4）: 835841.
［33］Kawamura K, Cheng Yuan, Suzuki N, et al.Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment ［J］.Proceedings of the National Academy of Sciences of the United States of America, 2013, 110（43）: 1747417479.
［34］Suzuki N, Yoshioka N, Takae S, et al.Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency ［J］.Human Reproduction （Oxford, England）, 2015, 30（3）: 608615.
［35］Wilkosz P, Greggains G D, Tanbo T G, et al.Female reproductive decline is determined by remaining ovarian reserve and age ［J］.PLOS One, 2014, 9（10）: e 108343.
［36］Gidoni Y S, Takefman J, Holzer H E, et al.Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report ［J］.Fertility and Sterility, 2008, 90（5）: 2008.e92008.12.
［37］Letur H.état des pratiques du don d'ovocytes en France et en Europe ［J］.Journal de Gynécologie, Obstétrique et Biologie de La Reproduction, 2007, 36（8）: 727737.
［38］Bedoschi G, Oktay K.Current approach to fertility preservation by embryo cryopreservation ［J］.Fertility and Sterility, 2013, 99（6）: 14961502.
［39］Andre H, Pimentel C, Veau S, et al.Pregnancies and obstetrical prognosis after oocyte donation in Turner Syndrome: A multicentric study ［J］.European Journal of Obstetrics & Gynecology and Reproductive Biology, 2019, 238: 7377.
［40］Bernard V, Donadille B, Zenaty D A, et al.Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome ［J］.Human Reproduction, 2016, 31（4）: 782788.